Top Buy
Security ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
TG Therapeutics Inc. | 20 | 4 | 4 | 0 | €14.95 | €27.00 | 80.552% |
Thermo Fisher Scientific Inc. | 27 | 0 | 6 | 0 | €532.10 | €568.09 | 6.764% |
Trinity Biotech ADR | 22 | 0 | 1 | 0 | €0.41 | - | - |
UCB S.A. | 2 | 0 | 0 | 0 | €121.50 | - | - |
Ultragenyx Pharmaceutical Inc. | 16 | 1 | 3 | 0 | €40.60 | €82.93 | 104.264% |
UnitedHealth Group Inc. | 33 | 1 | 7 | 0 | €457.35 | €543.72 | 18.885% |
United Therapeutics | 17 | 0 | 2 | 0 | €242.20 | €289.92 | 19.703% |
Universal Health Services B | 9 | 3 | 1 | 1 | €158.00 | €159.70 | 1.079% |
US Physical Therapy Inc. | 7 | 1 | 0 | 0 | €94.50 | €108.77 | 15.099% |
Vanda Pharmaceuticals | 4 | 0 | 1 | 0 | €4.38 | €5.00 | 14.155% |
Veeva Systems A | 2 | 0 | 0 | 0 | €187.00 | - | - |
Verastem Inc. | 9 | 0 | 0 | 0 | €8.60 | €27.03 | 214.314% |
Vericel Corp. | 1 | 0 | 0 | 0 | €43.00 | - | - |
Vertex Pharmaceuticals Inc. | 40 | 2 | 4 | 0 | €377.10 | €382.71 | 1.486% |
Viatris Inc. | 1 | 0 | 0 | 0 | €10.74 | - | - |
Viking Therapeutics Inc | 6 | 0 | 3 | 0 | €70.16 | €100.00 | 42.531% |
Viracta Therapeutics Inc. | 2 | 0 | 2 | 0 | €0.81 | - | - |
Virbac S.A. | 1 | 0 | 0 | 0 | €345.00 | - | - |
Vitrolife AB | 3 | 0 | 0 | 0 | €14.26 | - | - |
WAVE Life Sciences Ltd | 8 | 0 | 0 | 0 | €5.45 | €9.10 | 66.987% |
West Pharmaceutical Services Inc. | 6 | 0 | 0 | 0 | €341.80 | €369.72 | 8.170% |
X4 Pharmaceuticals, Inc. | 6 | 1 | 3 | 1 | €1.06 | €2.78 | 163.118% |
Xencor Inc. | 9 | 1 | 1 | 0 | €18.70 | €31.74 | 69.727% |
Xeris Biopharma Holdings Inc. | 4 | 0 | 0 | 0 | €1.64 | €4.39 | 168.253% |
XOMA Corp. | 6 | 0 | 3 | 0 | €23.00 | €68.78 | 199.040% |